Literature DB >> 12832623

Does a betaretrovirus infection trigger primary biliary cirrhosis?

Lizhe Xu1, Zhiwei Shen, Linsheng Guo, Brent Fodera, Adrian Keogh, Ruth Joplin, Barbara O'Donnell, James Aitken, William Carman, James Neuberger, Andrew Mason.   

Abstract

Patients with primary biliary cirrhosis develop progressive ductopenia associated with the production of antimitochondrial antibodies that react with a protein aberrantly expressed on biliary epithelial cells and peri-hepatic lymph nodes. Although no specific microbe has been identified, it is thought that an infectious agent triggers this autoimmune liver disease in genetically predisposed individuals. Previous serologic studies have provided evidence to suggest a viral association with primary biliary cirrhosis. Here we describe the identification of viral particles in biliary epithelium by electron microscopy and the cloning of exogenous retroviral nucleotide sequences from patients with primary biliary cirrhosis. The putative agent is referred to as the human betaretrovirus because it shares close homology with the murine mammary tumor virus and a human retrovirus cloned from breast cancer tissue. In vivo, we have found that the majority of patients with primary biliary cirrhosis have both RT-PCR and immunohistochemistry evidence of human betaretrovirus infection in lymph nodes. Moreover, the viral proteins colocalize to cells demonstrating aberrant autoantigen expression. In vitro, we have found that lymph node homogenates from patients with primary biliary cirrhosis can induce autoantigen expression in normal biliary epithelial cells in coculture. Normal biliary epithelial cells also develop the phenotypic manifestation of primary biliary cirrhosis when cocultivated in serial passage with supernatants containing the human betaretrovirus or the murine mammary tumor virus, providing a model to test Koch's postulates in vitro.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832623      PMCID: PMC166250          DOI: 10.1073/pnas.1433063100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  28 in total

1.  Immunopathogenesis of primary biliary cirrhosis.

Authors:  Akiyoshi Nishio; Emmet B Keeffe; M Eric Gershwin
Journal:  Semin Liver Dis       Date:  2002-08       Impact factor: 6.115

2.  Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis.

Authors:  T Sadamoto; R Joplin; A Keogh; A Mason; W Carman; J Neuberger
Journal:  Lancet       Date:  1998-11-14       Impact factor: 79.321

3.  Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis.

Authors:  J Van de Water; L B Gerson; L D Ferrell; J R Lake; R L Coppel; K P Batts; R H Wiesner; M E Gershwin
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

4.  Detection of multiple, novel reverse transcriptase coding sequences in human nucleic acids: relation to primate retroviruses.

Authors:  A Shih; R Misra; M G Rush
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  The human biliary epithelial cell plasma membrane antigen in primary biliary cirrhosis: pyruvate dehydrogenase X?

Authors:  R E Joplin; L L Wallace; J G Lindsay; J M Palmer; S J Yeaman; J M Neuberger
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

6.  Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders.

Authors:  A L Mason; L Xu; L Guo; S Munoz; J B Jaspan; M Bryer-Ash; Y Cao; D M Sander; Y Shoenfeld; A Ahmed; J Van de Water; M E Gershwin; R F Garry
Journal:  Lancet       Date:  1998-05-30       Impact factor: 79.321

7.  Expression of mouse mammary tumor virus-like env gene sequences in human breast cancer.

Authors:  Y Wang; V Go; J F Holland; S M Melana; B G Pogo
Journal:  Clin Cancer Res       Date:  1998-10       Impact factor: 12.531

8.  Detection of mammary tumor virus env gene-like sequences in human breast cancer.

Authors:  Y Wang; J F Holland; I J Bleiweiss; S Melana; X Liu; I Pelisson; A Cantarella; K Stellrecht; S Mani; B G Pogo
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

9.  Relationship between receptor and mammary tumour virus production after stimulation by glucocorticoid.

Authors:  G Shyamala; C Dickson
Journal:  Nature       Date:  1976-07-08       Impact factor: 49.962

10.  Recurrence of primary biliary cirrhosis after liver transplantation.

Authors:  J Neuberger; B Portmann; B R Macdougall; R Y Calne; R Williams
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

View more
  68 in total

Review 1.  Genetics of liver disease: immunogenetics and disease pathogenesis.

Authors:  P T Donaldson
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

2.  Mouse retroviruses and chronic fatigue syndrome: Does X (or P) mark the spot?

Authors:  Valerie Courgnaud; Jean-Luc Battini; Marc Sitbon; Andrew L Mason
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 3.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

4.  An immunoreceptor tyrosine activation motif in the mouse mammary tumor virus envelope protein plays a role in virus-induced mammary tumors.

Authors:  Susan R Ross; John W Schmidt; Elad Katz; Laura Cappelli; Stacy Hultine; Phyllis Gimotty; John G Monroe
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

5.  Primary biliary cirrhosis after aortoiliac reconstruction surgery using a Y-graft.

Authors:  Tomoko Inoue; Katsuya Shiraki; Hiroyuki Fuke; Yutaka Yamanaka; Kazumi Miyashita; Keiichi Ito; Masahiro Suzuki; Kazushi Sugimoto; Kazumoto Murata; Takeshi Nakano
Journal:  World J Gastroenterol       Date:  2005-10-21       Impact factor: 5.742

Review 6.  Pathogenesis of primary biliary cirrhosis.

Authors:  David E J Jones
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

7.  Randomized clinical trial: Combination antiretroviral therapy with tenofovir-emtricitabine and lopinavir-ritonavir in patients with primary biliary cholangitis.

Authors:  Ellina Lytvyak; Ishwar Hosamani; Aldo J Montano-Loza; Lynora Saxinger; Andrew L Mason
Journal:  Can Liver J       Date:  2019-01-09

8.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

Review 9.  The genetics of complex cholestatic disorders.

Authors:  Gideon M Hirschfield; Roger W Chapman; Tom H Karlsen; Frank Lammert; Konstantinos N Lazaridis; Andrew L Mason
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Questionnaire based assessment of risk factors for primary biliary cirrhosis.

Authors:  Craig Lammert; Douglas L Nguyen; Brian D Juran; Erik Schlicht; Joseph J Larson; Elizabeth J Atkinson; Konstantinos N Lazaridis
Journal:  Dig Liver Dis       Date:  2013-03-11       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.